img

Global PEG-modified Drugs Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global PEG-modified Drugs Market Insights, Forecast to 2034

Polyethylene glycol modified drug refers to a method of drug modification that combines polyethylene glycol molecules with drug molecules to improve the properties, pharmacokinetics and pharmacodynamic properties of drugs. This modification is often used to improve drug solubility, stability, bioavailability, and drug distribution.
Market Analysis and InsightsGlobal PEG-modified Drugs Market
Global PEG-modified Drugs market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, PEG-modified Drugs industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, PEG-modified Drugs key companies include Merck Sharp & Dohme, Baxalta Inc., Amgen Inc., Roche, UCB S.A., Enzon, Horizon Pharma Plc, Biogen Inc. and Qilu Pharmaceutical Co., Ltd., etc. Merck Sharp & Dohme, Baxalta Inc., Amgen Inc. are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of PEG-modified Drugs were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole PEG-modified Drugs market and estimated to attract more attentions from industry insiders and investors.
PEG-modified Drugs can be divided into PEG Amidation, PEGylation, PEG Peptidation and PEG Etherification, etc. PEG Amidation is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
PEG-modified Drugs is widely used in various fields, such as Cancer Treatment, Diabetes Treatment, Immunomodulatory and Anti-inflammatory Treatment, etc. Cancer Treatment provides greatest supports to the PEG-modified Drugs industry development. In 2022, global % revenue of PEG-modified Drugs went into Cancer Treatment filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global PEG-modified Drugs market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global PEG-modified Drugs market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Merck Sharp & Dohme
Baxalta Inc.
Amgen Inc.
Roche
UCB S.A.
Enzon
Horizon Pharma Plc
Biogen Inc.
Qilu Pharmaceutical Co., Ltd.
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Changchun Genescience Pharmaceutical Co., Ltd.
Xiamen Amoytop Biotech Co., Ltd.
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Hansoh Pharmaceuticak Group Co.,Ltd.
SunBio
Xiamen Sano banger Biotechnology Co., Ltd
Segment by Type
PEG Amidation
PEGylation
PEG Peptidation
PEG Etherification
Other Combinations

Segment by Application


Cancer Treatment
Diabetes Treatment
Immunomodulatory
Anti-inflammatory Treatment
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, PEG-modified Drugs introduction, etc. PEG-modified Drugs Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of PEG-modified Drugs
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PEG-modified Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 PEG Amidation
1.2.3 PEGylation
1.2.4 PEG Peptidation
1.2.5 PEG Etherification
1.2.6 Other Combinations
1.3 Market by Application
1.3.1 Global PEG-modified Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Cancer Treatment
1.3.3 Diabetes Treatment
1.3.4 Immunomodulatory
1.3.5 Anti-inflammatory Treatment
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global PEG-modified Drugs Market Perspective (2018-2033)
2.2 Global PEG-modified Drugs Growth Trends by Region
2.2.1 PEG-modified Drugs Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 PEG-modified Drugs Historic Market Size by Region (2018-2023)
2.2.3 PEG-modified Drugs Forecasted Market Size by Region (2024-2033)
2.3 PEG-modified Drugs Market Dynamics
2.3.1 PEG-modified Drugs Industry Trends
2.3.2 PEG-modified Drugs Market Drivers
2.3.3 PEG-modified Drugs Market Challenges
2.3.4 PEG-modified Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue PEG-modified Drugs by Players
3.1.1 Global PEG-modified Drugs Revenue by Players (2018-2023)
3.1.2 Global PEG-modified Drugs Revenue Market Share by Players (2018-2023)
3.2 Global PEG-modified Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of PEG-modified Drugs, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global PEG-modified Drugs Market Concentration Ratio
3.4.1 Global PEG-modified Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PEG-modified Drugs Revenue in 2022
3.5 Global Key Players of PEG-modified Drugs Head office and Area Served
3.6 Global Key Players of PEG-modified Drugs, Product and Application
3.7 Global Key Players of PEG-modified Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 PEG-modified Drugs Breakdown Data by Type
4.1 Global PEG-modified Drugs Historic Market Size by Type (2018-2023)
4.2 Global PEG-modified Drugs Forecasted Market Size by Type (2024-2033)
5 PEG-modified Drugs Breakdown Data by Application
5.1 Global PEG-modified Drugs Historic Market Size by Application (2018-2023)
5.2 Global PEG-modified Drugs Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America PEG-modified Drugs Market Size (2018-2033)
6.2 North America PEG-modified Drugs Market Size by Type
6.2.1 North America PEG-modified Drugs Market Size by Type (2018-2023)
6.2.2 North America PEG-modified Drugs Market Size by Type (2024-2033)
6.2.3 North America PEG-modified Drugs Market Share by Type (2018-2033)
6.3 North America PEG-modified Drugs Market Size by Application
6.3.1 North America PEG-modified Drugs Market Size by Application (2018-2023)
6.3.2 North America PEG-modified Drugs Market Size by Application (2024-2033)
6.3.3 North America PEG-modified Drugs Market Share by Application (2018-2033)
6.4 North America PEG-modified Drugs Market Size by Country
6.4.1 North America PEG-modified Drugs Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America PEG-modified Drugs Market Size by Country (2018-2023)
6.4.3 North America PEG-modified Drugs Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe PEG-modified Drugs Market Size (2018-2033)
7.2 Europe PEG-modified Drugs Market Size by Type
7.2.1 Europe PEG-modified Drugs Market Size by Type (2018-2023)
7.2.2 Europe PEG-modified Drugs Market Size by Type (2024-2033)
7.2.3 Europe PEG-modified Drugs Market Share by Type (2018-2033)
7.3 Europe PEG-modified Drugs Market Size by Application
7.3.1 Europe PEG-modified Drugs Market Size by Application (2018-2023)
7.3.2 Europe PEG-modified Drugs Market Size by Application (2024-2033)
7.3.3 Europe PEG-modified Drugs Market Share by Application (2018-2033)
7.4 Europe PEG-modified Drugs Market Size by Country
7.4.1 Europe PEG-modified Drugs Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe PEG-modified Drugs Market Size by Country (2018-2023)
7.4.3 Europe PEG-modified Drugs Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China PEG-modified Drugs Market Size (2018-2033)
8.2 China PEG-modified Drugs Market Size by Type
8.2.1 China PEG-modified Drugs Market Size by Type (2018-2023)
8.2.2 China PEG-modified Drugs Market Size by Type (2024-2033)
8.2.3 China PEG-modified Drugs Market Share by Type (2018-2033)
8.3 China PEG-modified Drugs Market Size by Application
8.3.1 China PEG-modified Drugs Market Size by Application (2018-2023)
8.3.2 China PEG-modified Drugs Market Size by Application (2024-2033)
8.3.3 China PEG-modified Drugs Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia PEG-modified Drugs Market Size (2018-2033)
9.2 Asia PEG-modified Drugs Market Size by Type
9.2.1 Asia PEG-modified Drugs Market Size by Type (2018-2023)
9.2.2 Asia PEG-modified Drugs Market Size by Type (2024-2033)
9.2.3 Asia PEG-modified Drugs Market Share by Type (2018-2033)
9.3 Asia PEG-modified Drugs Market Size by Application
9.3.1 Asia PEG-modified Drugs Market Size by Application (2018-2023)
9.3.2 Asia PEG-modified Drugs Market Size by Application (2024-2033)
9.3.3 Asia PEG-modified Drugs Market Share by Application (2018-2033)
9.4 Asia PEG-modified Drugs Market Size by Region
9.4.1 Asia PEG-modified Drugs Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia PEG-modified Drugs Market Size by Region (2018-2023)
9.4.3 Asia PEG-modified Drugs Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America PEG-modified Drugs Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America PEG-modified Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America PEG-modified Drugs Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America PEG-modified Drugs Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America PEG-modified Drugs Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America PEG-modified Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America PEG-modified Drugs Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America PEG-modified Drugs Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America PEG-modified Drugs Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America PEG-modified Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America PEG-modified Drugs Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America PEG-modified Drugs Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America PEG-modified Drugs Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck Sharp & Dohme
11.1.1 Merck Sharp & Dohme Company Details
11.1.2 Merck Sharp & Dohme Business Overview
11.1.3 Merck Sharp & Dohme PEG-modified Drugs Introduction
11.1.4 Merck Sharp & Dohme Revenue in PEG-modified Drugs Business (2018-2023)
11.1.5 Merck Sharp & Dohme Recent Developments
11.2 Baxalta Inc.
11.2.1 Baxalta Inc. Company Details
11.2.2 Baxalta Inc. Business Overview
11.2.3 Baxalta Inc. PEG-modified Drugs Introduction
11.2.4 Baxalta Inc. Revenue in PEG-modified Drugs Business (2018-2023)
11.2.5 Baxalta Inc. Recent Developments
11.3 Amgen Inc.
11.3.1 Amgen Inc. Company Details
11.3.2 Amgen Inc. Business Overview
11.3.3 Amgen Inc. PEG-modified Drugs Introduction
11.3.4 Amgen Inc. Revenue in PEG-modified Drugs Business (2018-2023)
11.3.5 Amgen Inc. Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche PEG-modified Drugs Introduction
11.4.4 Roche Revenue in PEG-modified Drugs Business (2018-2023)
11.4.5 Roche Recent Developments
11.5 UCB S.A.
11.5.1 UCB S.A. Company Details
11.5.2 UCB S.A. Business Overview
11.5.3 UCB S.A. PEG-modified Drugs Introduction
11.5.4 UCB S.A. Revenue in PEG-modified Drugs Business (2018-2023)
11.5.5 UCB S.A. Recent Developments
11.6 Enzon
11.6.1 Enzon Company Details
11.6.2 Enzon Business Overview
11.6.3 Enzon PEG-modified Drugs Introduction
11.6.4 Enzon Revenue in PEG-modified Drugs Business (2018-2023)
11.6.5 Enzon Recent Developments
11.7 Horizon Pharma Plc
11.7.1 Horizon Pharma Plc Company Details
11.7.2 Horizon Pharma Plc Business Overview
11.7.3 Horizon Pharma Plc PEG-modified Drugs Introduction
11.7.4 Horizon Pharma Plc Revenue in PEG-modified Drugs Business (2018-2023)
11.7.5 Horizon Pharma Plc Recent Developments
11.8 Biogen Inc.
11.8.1 Biogen Inc. Company Details
11.8.2 Biogen Inc. Business Overview
11.8.3 Biogen Inc. PEG-modified Drugs Introduction
11.8.4 Biogen Inc. Revenue in PEG-modified Drugs Business (2018-2023)
11.8.5 Biogen Inc. Recent Developments
11.9 Qilu Pharmaceutical Co., Ltd.
11.9.1 Qilu Pharmaceutical Co., Ltd. Company Details
11.9.2 Qilu Pharmaceutical Co., Ltd. Business Overview
11.9.3 Qilu Pharmaceutical Co., Ltd. PEG-modified Drugs Introduction
11.9.4 Qilu Pharmaceutical Co., Ltd. Revenue in PEG-modified Drugs Business (2018-2023)
11.9.5 Qilu Pharmaceutical Co., Ltd. Recent Developments
11.10 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
11.10.1 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Company Details
11.10.2 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Business Overview
11.10.3 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. PEG-modified Drugs Introduction
11.10.4 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Revenue in PEG-modified Drugs Business (2018-2023)
11.10.5 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Recent Developments
11.11 Changchun Genescience Pharmaceutical Co., Ltd.
11.11.1 Changchun Genescience Pharmaceutical Co., Ltd. Company Details
11.11.2 Changchun Genescience Pharmaceutical Co., Ltd. Business Overview
11.11.3 Changchun Genescience Pharmaceutical Co., Ltd. PEG-modified Drugs Introduction
11.11.4 Changchun Genescience Pharmaceutical Co., Ltd. Revenue in PEG-modified Drugs Business (2018-2023)
11.11.5 Changchun Genescience Pharmaceutical Co., Ltd. Recent Developments
11.12 Xiamen Amoytop Biotech Co., Ltd.
11.12.1 Xiamen Amoytop Biotech Co., Ltd. Company Details
11.12.2 Xiamen Amoytop Biotech Co., Ltd. Business Overview
11.12.3 Xiamen Amoytop Biotech Co., Ltd. PEG-modified Drugs Introduction
11.12.4 Xiamen Amoytop Biotech Co., Ltd. Revenue in PEG-modified Drugs Business (2018-2023)
11.12.5 Xiamen Amoytop Biotech Co., Ltd. Recent Developments
11.13 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
11.13.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Details
11.13.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Business Overview
11.13.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. PEG-modified Drugs Introduction
11.13.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Revenue in PEG-modified Drugs Business (2018-2023)
11.13.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments
11.14 Hansoh Pharmaceuticak Group Co.,Ltd.
11.14.1 Hansoh Pharmaceuticak Group Co.,Ltd. Company Details
11.14.2 Hansoh Pharmaceuticak Group Co.,Ltd. Business Overview
11.14.3 Hansoh Pharmaceuticak Group Co.,Ltd. PEG-modified Drugs Introduction
11.14.4 Hansoh Pharmaceuticak Group Co.,Ltd. Revenue in PEG-modified Drugs Business (2018-2023)
11.14.5 Hansoh Pharmaceuticak Group Co.,Ltd. Recent Developments
11.15 SunBio
11.15.1 SunBio Company Details
11.15.2 SunBio Business Overview
11.15.3 SunBio PEG-modified Drugs Introduction
11.15.4 SunBio Revenue in PEG-modified Drugs Business (2018-2023)
11.15.5 SunBio Recent Developments
11.16 Xiamen Sano banger Biotechnology Co., Ltd
11.16.1 Xiamen Sano banger Biotechnology Co., Ltd Company Details
11.16.2 Xiamen Sano banger Biotechnology Co., Ltd Business Overview
11.16.3 Xiamen Sano banger Biotechnology Co., Ltd PEG-modified Drugs Introduction
11.16.4 Xiamen Sano banger Biotechnology Co., Ltd Revenue in PEG-modified Drugs Business (2018-2023)
11.16.5 Xiamen Sano banger Biotechnology Co., Ltd Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global PEG-modified Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of PEG Amidation
Table 3. Key Players of PEGylation
Table 4. Key Players of PEG Peptidation
Table 5. Key Players of PEG Etherification
Table 6. Key Players of Other Combinations
Table 7. Global PEG-modified Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 8. Global PEG-modified Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global PEG-modified Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global PEG-modified Drugs Market Share by Region (2018-2023)
Table 11. Global PEG-modified Drugs Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global PEG-modified Drugs Market Share by Region (2024-2033)
Table 13. PEG-modified Drugs Market Trends
Table 14. PEG-modified Drugs Market Drivers
Table 15. PEG-modified Drugs Market Challenges
Table 16. PEG-modified Drugs Market Restraints
Table 17. Global PEG-modified Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global PEG-modified Drugs Revenue Share by Players (2018-2023)
Table 19. Global Top PEG-modified Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PEG-modified Drugs as of 2022)
Table 20. Global PEG-modified Drugs Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by PEG-modified Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of PEG-modified Drugs, Headquarters and Area Served
Table 23. Global Key Players of PEG-modified Drugs, Product and Application
Table 24. Global Key Players of PEG-modified Drugs, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global PEG-modified Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global PEG-modified Drugs Revenue Market Share by Type (2018-2023)
Table 28. Global PEG-modified Drugs Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global PEG-modified Drugs Revenue Market Share by Type (2024-2033)
Table 30. Global PEG-modified Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global PEG-modified Drugs Revenue Share by Application (2018-2023)
Table 32. Global PEG-modified Drugs Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global PEG-modified Drugs Revenue Share by Application (2024-2033)
Table 34. North America PEG-modified Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America PEG-modified Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 36. North America PEG-modified Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America PEG-modified Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 38. North America PEG-modified Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. North America PEG-modified Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America PEG-modified Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 41. Europe PEG-modified Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe PEG-modified Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 43. Europe PEG-modified Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe PEG-modified Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 45. Europe PEG-modified Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Europe PEG-modified Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe PEG-modified Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 48. China PEG-modified Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 49. China PEG-modified Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 50. China PEG-modified Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 51. China PEG-modified Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 52. Asia PEG-modified Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia PEG-modified Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 54. Asia PEG-modified Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia PEG-modified Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 56. Asia PEG-modified Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 57. Asia PEG-modified Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia PEG-modified Drugs Market Size by Region (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America PEG-modified Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America PEG-modified Drugs Market Size by Type (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America PEG-modified Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America PEG-modified Drugs Market Size by Application (2024-2033) & (US$ Million)
Table 63. Middle East, Africa, and Latin America PEG-modified Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 64. Middle East, Africa, and Latin America PEG-modified Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America PEG-modified Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 66. Merck Sharp & Dohme Company Details
Table 67. Merck Sharp & Dohme Business Overview
Table 68. Merck Sharp & Dohme PEG-modified Drugs Product
Table 69. Merck Sharp & Dohme Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 70. Merck Sharp & Dohme Recent Developments
Table 71. Baxalta Inc. Company Details
Table 72. Baxalta Inc. Business Overview
Table 73. Baxalta Inc. PEG-modified Drugs Product
Table 74. Baxalta Inc. Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 75. Baxalta Inc. Recent Developments
Table 76. Amgen Inc. Company Details
Table 77. Amgen Inc. Business Overview
Table 78. Amgen Inc. PEG-modified Drugs Product
Table 79. Amgen Inc. Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 80. Amgen Inc. Recent Developments
Table 81. Roche Company Details
Table 82. Roche Business Overview
Table 83. Roche PEG-modified Drugs Product
Table 84. Roche Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 85. Roche Recent Developments
Table 86. UCB S.A. Company Details
Table 87. UCB S.A. Business Overview
Table 88. UCB S.A. PEG-modified Drugs Product
Table 89. UCB S.A. Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 90. UCB S.A. Recent Developments
Table 91. Enzon Company Details
Table 92. Enzon Business Overview
Table 93. Enzon PEG-modified Drugs Product
Table 94. Enzon Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 95. Enzon Recent Developments
Table 96. Horizon Pharma Plc Company Details
Table 97. Horizon Pharma Plc Business Overview
Table 98. Horizon Pharma Plc PEG-modified Drugs Product
Table 99. Horizon Pharma Plc Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 100. Horizon Pharma Plc Recent Developments
Table 101. Biogen Inc. Company Details
Table 102. Biogen Inc. Business Overview
Table 103. Biogen Inc. PEG-modified Drugs Product
Table 104. Biogen Inc. Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 105. Biogen Inc. Recent Developments
Table 106. Qilu Pharmaceutical Co., Ltd. Company Details
Table 107. Qilu Pharmaceutical Co., Ltd. Business Overview
Table 108. Qilu Pharmaceutical Co., Ltd. PEG-modified Drugs Product
Table 109. Qilu Pharmaceutical Co., Ltd. Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 110. Qilu Pharmaceutical Co., Ltd. Recent Developments
Table 111. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Company Details
Table 112. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Business Overview
Table 113. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. PEG-modified Drugs Product
Table 114. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 115. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Recent Developments
Table 116. Changchun Genescience Pharmaceutical Co., Ltd. Company Details
Table 117. Changchun Genescience Pharmaceutical Co., Ltd. Business Overview
Table 118. Changchun Genescience Pharmaceutical Co., Ltd. PEG-modified Drugs Product
Table 119. Changchun Genescience Pharmaceutical Co., Ltd. Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 120. Changchun Genescience Pharmaceutical Co., Ltd. Recent Developments
Table 121. Xiamen Amoytop Biotech Co., Ltd. Company Details
Table 122. Xiamen Amoytop Biotech Co., Ltd. Business Overview
Table 123. Xiamen Amoytop Biotech Co., Ltd. PEG-modified Drugs Product
Table 124. Xiamen Amoytop Biotech Co., Ltd. Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 125. Xiamen Amoytop Biotech Co., Ltd. Recent Developments
Table 126. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Details
Table 127. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Business Overview
Table 128. Jiangsu Hengrui Pharmaceuticals Co., Ltd. PEG-modified Drugs Product
Table 129. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 130. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments
Table 131. Hansoh Pharmaceuticak Group Co.,Ltd. Company Details
Table 132. Hansoh Pharmaceuticak Group Co.,Ltd. Business Overview
Table 133. Hansoh Pharmaceuticak Group Co.,Ltd. PEG-modified Drugs Product
Table 134. Hansoh Pharmaceuticak Group Co.,Ltd. Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 135. Hansoh Pharmaceuticak Group Co.,Ltd. Recent Developments
Table 136. SunBio Company Details
Table 137. SunBio Business Overview
Table 138. SunBio PEG-modified Drugs Product
Table 139. SunBio Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 140. SunBio Recent Developments
Table 141. Xiamen Sano banger Biotechnology Co., Ltd Company Details
Table 142. Xiamen Sano banger Biotechnology Co., Ltd Business Overview
Table 143. Xiamen Sano banger Biotechnology Co., Ltd PEG-modified Drugs Product
Table 144. Xiamen Sano banger Biotechnology Co., Ltd Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 145. Xiamen Sano banger Biotechnology Co., Ltd Recent Developments
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global PEG-modified Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global PEG-modified Drugs Market Share by Type: 2022 VS 2033
Figure 3. PEG Amidation Features
Figure 4. PEGylation Features
Figure 5. PEG Peptidation Features
Figure 6. PEG Etherification Features
Figure 7. Other Combinations Features
Figure 8. Global PEG-modified Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 9. Global PEG-modified Drugs Market Share by Application: 2022 VS 2033
Figure 10. Cancer Treatment Case Studies
Figure 11. Diabetes Treatment Case Studies
Figure 12. Immunomodulatory Case Studies
Figure 13. Anti-inflammatory Treatment Case Studies
Figure 14. Others Case Studies
Figure 15. PEG-modified Drugs Report Years Considered
Figure 16. Global PEG-modified Drugs Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global PEG-modified Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global PEG-modified Drugs Market Share by Region: 2022 VS 2033
Figure 19. Global PEG-modified Drugs Market Share by Players in 2022
Figure 20. Global Top PEG-modified Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PEG-modified Drugs as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by PEG-modified Drugs Revenue in 2022
Figure 22. North America PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America PEG-modified Drugs Market Share by Type (2018-2033)
Figure 24. North America PEG-modified Drugs Market Share by Application (2018-2033)
Figure 25. North America PEG-modified Drugs Market Share by Country (2018-2033)
Figure 26. United States PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Canada PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Europe PEG-modified Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 29. Europe PEG-modified Drugs Market Share by Type (2018-2033)
Figure 30. Europe PEG-modified Drugs Market Share by Application (2018-2033)
Figure 31. Europe PEG-modified Drugs Market Share by Country (2018-2033)
Figure 32. Germany PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. France PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. U.K. PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Italy PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Russia PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Nordic Countries PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. China PEG-modified Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 39. China PEG-modified Drugs Market Share by Type (2018-2033)
Figure 40. China PEG-modified Drugs Market Share by Application (2018-2033)
Figure 41. Asia PEG-modified Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 42. Asia PEG-modified Drugs Market Share by Type (2018-2033)
Figure 43. Asia PEG-modified Drugs Market Share by Application (2018-2033)
Figure 44. Asia PEG-modified Drugs Market Share by Region (2018-2033)
Figure 45. Japan PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. South Korea PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. China Taiwan PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Southeast Asia PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. India PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Australia PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America PEG-modified Drugs Market Size YoY (2018-2033) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America PEG-modified Drugs Market Share by Type (2018-2033)
Figure 53. Middle East, Africa, and Latin America PEG-modified Drugs Market Share by Application (2018-2033)
Figure 54. Middle East, Africa, and Latin America PEG-modified Drugs Market Share by Country (2018-2033)
Figure 55. Brazil PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Mexico PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Turkey PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Saudi Arabia PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Israel PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. GCC Countries PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 61. Merck Sharp & Dohme Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 62. Baxalta Inc. Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 63. Amgen Inc. Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 64. Roche Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 65. UCB S.A. Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 66. Enzon Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 67. Horizon Pharma Plc Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 68. Biogen Inc. Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 69. Qilu Pharmaceutical Co., Ltd. Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 70. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 71. Changchun Genescience Pharmaceutical Co., Ltd. Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 72. Xiamen Amoytop Biotech Co., Ltd. Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 73. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 74. Hansoh Pharmaceuticak Group Co.,Ltd. Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 75. SunBio Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 76. Xiamen Sano banger Biotechnology Co., Ltd Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries